Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Kaerus Bioscience is dedicated to discovering and developing targeted therapeutics for rare neurodevelopmental disorders. By leveraging the latest advances in human genetics, the company is at the forefront of creating innovative treatments for genetic syndromes, such as Fragile X Syndrome. With a focus on precision medicine, Kaerus aims to address the unmet needs of patients with these challenging conditions, where traditiona...
Kaerus Bioscience is dedicated to discovering and developing targeted therapeutics for rare neurodevelopmental disorders. By leveraging the latest advances in human genetics, the company is at the forefront of creating innovative treatments for genetic syndromes, such as Fragile X Syndrome. With a focus on precision medicine, Kaerus aims to address the unmet needs of patients with these challenging conditions, where traditional treatments have been limited or ineffective.

List your booth number for exhibitions, ask us